183 related articles for article (PubMed ID: 19526526)
1. Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology.
Uzzaman A; Maric I; Noel P; Kettelhut BV; Metcalfe DD; Carter MC
Pediatr Blood Cancer; 2009 Oct; 53(4):629-34. PubMed ID: 19526526
[TBL] [Abstract][Full Text] [Related]
2. Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.
Carter MC; Clayton ST; Komarow HD; Brittain EH; Scott LM; Cantave D; Gaskins DM; Maric I; Metcalfe DD
J Allergy Clin Immunol; 2015 Dec; 136(6):1673-1679.e3. PubMed ID: 26044856
[TBL] [Abstract][Full Text] [Related]
3. Abnormal bone marrow histopathology in paediatric mastocytosis.
Carter MC; Metcalfe DD; Clark AS; Wayne AS; Maric I
Br J Haematol; 2015 Mar; 168(6):865-73. PubMed ID: 25429914
[TBL] [Abstract][Full Text] [Related]
4. Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients.
Kettelhut BV; Parker RI; Travis WD; Metcalfe DD
Am J Clin Pathol; 1989 May; 91(5):558-62. PubMed ID: 2470248
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
[TBL] [Abstract][Full Text] [Related]
6. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
[TBL] [Abstract][Full Text] [Related]
7. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
8. Mastocytosis in children: a single-center long-term follow-up study.
Popadic S; Lalosevic J; Lekic B; Gajić-Veljic M; Bonaci-Nikolic B; Nikolic M
Int J Dermatol; 2023 May; 62(5):616-620. PubMed ID: 36807903
[TBL] [Abstract][Full Text] [Related]
9. Clinical and histopathological aspects of cutaneous mastocytosis.
Wolff K; Komar M; Petzelbauer P
Leuk Res; 2001 Jul; 25(7):519-28. PubMed ID: 11377676
[TBL] [Abstract][Full Text] [Related]
10. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.
Berezowska S; Flaig MJ; Ruëff F; Walz C; Haferlach T; Krokowski M; Kerler R; Petat-Dutter K; Horny HP; Sotlar K
Mod Pathol; 2014 Jan; 27(1):19-29. PubMed ID: 23807778
[TBL] [Abstract][Full Text] [Related]
11. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis.
Wiechers T; Rabenhorst A; Schick T; Preussner LM; Förster A; Valent P; Horny HP; Sotlar K; Hartmann K
J Allergy Clin Immunol; 2015 Dec; 136(6):1581-1590.e3. PubMed ID: 26152315
[TBL] [Abstract][Full Text] [Related]
12. Childhood mastocytosis.
Torrelo A; Alvarez-Twose I; Escribano L
Curr Opin Pediatr; 2012 Aug; 24(4):480-6. PubMed ID: 22790101
[TBL] [Abstract][Full Text] [Related]
13. Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology.
Akin C; Schwartz LB; Kitoh T; Obayashi H; Worobec AS; Scott LM; Metcalfe DD
Blood; 2000 Aug; 96(4):1267-73. PubMed ID: 10942367
[TBL] [Abstract][Full Text] [Related]
14. Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow.
Johnson MR; Verstovsek S; Jorgensen JL; Manshouri T; Luthra R; Jones DM; Bueso-Ramos CE; Medeiros LJ; Huh YO
Mod Pathol; 2009 Jan; 22(1):50-7. PubMed ID: 19116630
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.
Bulai Livideanu C; Apoil PA; Lepage B; Eischen M; Laurent C; Laharrague P; Lamant L; Tournier E; Tavitian S; Pouplard C; Recher C; Laroche M; Mailhol C; Dubreuil P; Hermine O; Blancher A; Paul C
Clin Exp Allergy; 2016 Jan; 46(1):133-41. PubMed ID: 26767494
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis.
Godt O; Proksch E; Streit V; Christophers E
Dermatology; 1997; 195(1):35-9. PubMed ID: 9267734
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow involvement in cutaneous mastocytosis.
Fearfield LA; Francis N; Henry K; Costello C; Bunker CB
Br J Dermatol; 2001 Mar; 144(3):561-6. PubMed ID: 11260015
[TBL] [Abstract][Full Text] [Related]
18. Pediatric mastocytosis.
Hussain SH
Curr Opin Pediatr; 2020 Aug; 32(4):531-538. PubMed ID: 32692050
[TBL] [Abstract][Full Text] [Related]
19. Systemic mastocytosis: a diagnostic challenge.
Bateman HE; Shroff V; Centeno LV; Bielory L
Ann Allergy Asthma Immunol; 1995 May; 74(5):379-86. PubMed ID: 7749967
[TBL] [Abstract][Full Text] [Related]
20. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]